None of these treatment options worked for me and led to my highest weight of 330 pounds
10.1016/j.ejphar.2019.172593 [DOI] [PubMed] [Google Scholar] Tabata Y., Nagano A., Ikada Y
The FDA-approved Wegovy label, for example, describes semaglutide as a GLP-1 receptor agonist used with reduced calories and increased physical activity for long-term weight reduction in certain adults and adolescents, and for reducing risk of major cardiovascular events in certain adults with cardiovascular disease and overweight or obesity
Karen Tang , MD, is an OB-GYN and founder of Thrive Gynecology
Nature 2011 472(7341):40 - 41 M
Yet, amidst their rising popularity, recent announcements from the FDA about compounded versions of these drugs have left many patients wondering: will compounded GLP-1 go away